Edition:
United Kingdom

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

4.75USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
398,451
52-wk High
$17.30
52-wk Low
$4.20

Chart for

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $846.68
Shares Outstanding(Mil.): 68.84
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.95 -- --
ROI: -129.83 9.01 14.96
ROE: -133.51 10.15 16.52

Earnings vs. Estimates